dihydrokainate has been researched along with 17-alpha-hydroxyprogesterone in 1 studies
| Studies (dihydrokainate) | Trials (dihydrokainate) | Recent Studies (post-2010) (dihydrokainate) | Studies (17-alpha-hydroxyprogesterone) | Trials (17-alpha-hydroxyprogesterone) | Recent Studies (post-2010) (17-alpha-hydroxyprogesterone) |
|---|---|---|---|---|---|
| 180 | 0 | 46 | 2,148 | 145 | 434 |
| Protein | Taxonomy | dihydrokainate (IC50) | 17-alpha-hydroxyprogesterone (IC50) |
|---|---|---|---|
| Glucocorticoid receptor | Homo sapiens (human) | 0.051 | |
| Glycine receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | 0.051 | |
| Adenosine receptor A3 | Homo sapiens (human) | 4.73 | |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 6.3 | |
| Androgen receptor | Rattus norvegicus (Norway rat) | 0.739 | |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 4.73 | |
| Glycine receptor subunit beta | Rattus norvegicus (Norway rat) | 0.051 | |
| Glycine receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | 0.051 | |
| Glycine receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | 0.051 | |
| Mitogen-activated protein kinase 3 | Homo sapiens (human) | 3.157 | |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 4.73 | |
| Sodium-dependent dopamine transporter | Homo sapiens (human) | 6.905 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
1 other study(ies) available for dihydrokainate and 17-alpha-hydroxyprogesterone
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |